Life Tech to Market Quidel's PCR-Based Infectious Disease Dxs in Europe
September 22, 2011
Life Tech to Market Quidel's PCR-Based Infectious Disease Dxs in Europe
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Quidel Continues to Advance Trio of MDx Initiatives; On Target to Complete All by End of '13
March 1, 2012 / PCR Insider - Dx Focus: Quidel Gets FDA OK for First Pair of Molecular Tests
January 5, 2012 / PCR Insider - FDA OK of Life Tech, Quidel C. Diff Assay Sets Stage for Future Cleared Tests on QuantStudio Dx
March 21, 2013 / PCR Insider - Quidel Expands Market for Flu Assay with Second Platform Approval
March 22, 2012 / PCR Insider - FDA Clears Quidel C. difficile Assay for Life Tech's QuantStudio Dx and 7500 Fast Dx PCR Instruments
March 18, 2013 / GenomeWeb Daily News